Browse by Journal Title

2021

Cannabidiol converts NF(κ)B into a tumor suppressor in glioblastoma with defined antioxidative properties.
Volmar, M.N.M. and Cheng, J. and Alenezi, H. and Richter, S. and Haug, A. and Hassan, Z. and Goldberg, M. and Li, Y. and Hou, M. and Herold-Mende, C. and Maire, C.L. and Lamszus, K. and Flüh, C. and Held-Feindt, J. and Gargiulo, G. and Topping, G.J. and Schilling, F. and Saur, D. and Schneider, G. and Synowitz, M. and Schick, J.A. and Kälin, R.E. and Glass, R.
Neuro-Oncology 23 (11): 1898-1910. November 2021

2018

Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
Szulzewsky, F. and Schwendinger, N. and Güneykaya, D. and Cimino, P.J. and Hambardzumyan, D. and Synowitz, M. and Holland, E.C. and Kettenmann, H.
Neuro-Oncology 20 (3): 355-366. 19 February 2018

2015

Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
Hu, F. and a Dzaye, O.D. and Hahn, A. and Yu, Y. and Scavetta, R.J. and Dittmar, G. and Kaczmarek, A.K. and Dunning, K.R. and Ricciardelli, C. and Rinnenthal, J.L. and Heppner, F.L. and Lehnardt, S. and Synowitz, M. and Wolf, S.A. and Kettenmann, H.
Neuro-Oncology 17 (2): 200-210. February 2015

2013

Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann, C. and Fuchs, S. and Monoranu, C.M. and Herrmann, P. and Smith, J. and Hohmann, T. and Grabiec, U. and Kessler, A.F. and Dehghani, F. and Loehr, M. and Ernestus, R.I. and Vince, G.H. and Stein, U.
Neuro-Oncology 15 (12): 1696-1709. December 2013

Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.
Vinnakota, K. and Hu, F. and Ku, M.C. and Georgieva, P.B. and Szulzewsky, F. and Pohlmann, A. and Waiczies, S. and Waiczies, H. and Niendorf, T. and Lehnardt, S. and Hanisch, U.K. and Synowitz, M. and Markovic, D.S. and Wolf, S.A. and Glass, R. and Kettenmann, H.
Neuro-Oncology 15 (11): 1457-1468. November 2013

2012

Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
Künkele, A. and De Preter, K. and Heukamp, L. and Thor, T. and Pajtler, K.W. and Hartmann, W. and Mittelbronn, M. and Grotzer, M.A. and Deubzer, H.E. and Speleman, F. and Schramm, A. and Eggert, A. and Schulte, J.H.
Neuro-Oncology 14 (7): 859-869. 1 July 2012